Page last updated: 2024-10-23

diminazene and Idiopathic Parkinson Disease

diminazene has been researched along with Idiopathic Parkinson Disease in 2 studies

Diminazene: An effective trypanocidal agent.
diminazene : A triazene derivative that is triazene in which each of the terminal nitrogens is substituted by a 4-carbamimidoylphenyl group.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (50.00)24.3611
2020's1 (50.00)2.80

Authors

AuthorsStudies
Gupta, S1
Tiwari, V1
Tiwari, P1
Mishra, A1
Hanif, K1
Shukla, S1
Lewandowski, NM1
Ju, S1
Verbitsky, M1
Ross, B1
Geddie, ML1
Rockenstein, E1
Adame, A1
Muhammad, A1
Vonsattel, JP1
Ringe, D1
Cote, L1
Lindquist, S1
Masliah, E1
Petsko, GA1
Marder, K1
Clark, LN1
Small, SA1

Other Studies

2 other studies available for diminazene and Idiopathic Parkinson Disease

ArticleYear
Angiotensin-Converting Enzyme 2 Activation Mitigates Behavioral Deficits and Neuroinflammatory Burden in 6-OHDA Induced Experimental Models of Parkinson's Disease.
    ACS chemical neuroscience, 2022, 05-18, Volume: 13, Issue:10

    Topics: Angiotensin I; Angiotensin-Converting Enzyme 2; Animals; Diminazene; Mice; Models, Theoretical; Oxid

2022
Polyamine pathway contributes to the pathogenesis of Parkinson disease.
    Proceedings of the National Academy of Sciences of the United States of America, 2010, Sep-28, Volume: 107, Issue:39

    Topics: Acetyltransferases; alpha-Synuclein; Animals; Brain Stem; Diminazene; Genetic Variation; Humans; Mag

2010